tiprankstipranks
Ikena Oncology (IKNA)
NASDAQ:IKNA
US Market

Ikena Oncology (IKNA) Financial Statements

90 Followers

Ikena Oncology Financial Overview

Ikena Oncology's market cap is currently ―. The company's EPS TTM is $-1.634; its P/E ratio is -0.83; Ikena Oncology is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 658.00K$ 1.19M$ 2.00M$ 5.31M$ 5.45M
Gross Profit$ 658.00K$ 1.19M$ 2.00M$ 5.31M$ 5.45M
EBIT$ -19.65M$ -17.34M$ -17.11M$ -14.95M$ -15.16M
EBITDA$ -19.66M--$ -15.25M$ -15.01M
Net Income Common Stockholders$ -19.49M$ -17.34M$ -17.11M$ -14.22M$ -14.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 175.47M$ 196.93M$ 157.31M$ 137.81M$ 156.95M
Total Assets$ 192.09M$ 215.34M$ 171.76M$ 152.40M$ 172.26M
Total Debt$ 11.69M$ 12.34M$ 4.99M$ 5.35M$ 5.69M
Net Debt$ -163.78M$ -184.59M$ -152.32M$ -132.46M$ -151.25M
Total Liabilities$ 22.34M$ 28.15M$ 15.06M$ 17.38M$ 25.29M
Stockholders Equity$ 169.76M$ 155.34M$ 156.70M$ 135.02M$ 146.97M
Cash Flow-
Free Cash Flow$ -22.09M--$ -19.94M$ -17.89M
Operating Cash Flow$ -21.82M$ -20.00M-$ -19.78M$ -17.66M
Investing Cash Flow$ 20.38M$ 31.89M-$ -10.81M$ 10.50M
Financing Cash Flow$ 60.00K$ 38.92M--$ 1.00K
Currency in USD

Ikena Oncology Earnings and Revenue History

Ikena Oncology Debt to Assets

Ikena Oncology Cash Flow

Ikena Oncology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis